It is a chemicals public limited company based in Mumbai, Maharashtra, India, established in 1990.
1990 | Mumbai, Maharashtra, India | ActiveEuclid Pharmaceuticals Limited, a active public limited company, was established on 14 November 1990 in Mumbai, Maharashtra, India. Engaging in medicinal chemical & botanical products within the manufacturing sector, it holds CIN: U17120MH1990PLC058963. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹5.00 M.
It upholds a compliant status. Its leadership includes Shantilal Javerchand Jain (Director), Lata Shantilal Jain (Director), Varsha Shantilal Jain (Director). Past directors included Shirish Shantilal Jain. Its latest AGM occurred on 29 September 2025, with the balance sheet filed on 31 March 2025. It is based at Varsha 13 Adarsh Socramchandra Lane Extn Malad West, Mumbai, Maharashtra, 400064.
U17120MH1990PLC058963
058963
14 November 1990
₹5.00 M
₹5.00 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Euclid Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shantilal Javerchand Jain | Director | 28 Sep 2005 | Current |
| Lata Shantilal Jain | Director | 05 Feb 2016 | Current |
| Varsha Shantilal Jain | Director | 28 Sep 2005 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 09 Feb 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Euclid Pharmaceuticals Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, Euclid Pharmaceuticals had a promoter holding of 49.20% and a public holding of 50.80%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Euclid Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Euclid Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Euclid Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Euclid Pharmaceuticals Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records. was recorded as a recent event.
Euclid Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.
Lata Shantilal Jain was appointed as a Director was appointed as a Director on 05 Feb 2016 & has been associated with this company since 9 years 11 months . was recorded as a recent event.
The activity Shantilal Javerchand Jain was appointed as a Director was appointed as a Director on 28 Sep 2005 & has been associated with this company since 20 years 3 months . was completed.
The activity Varsha Shantilal Jain was appointed as a Director was appointed as a Director on 28 Sep 2005 & has been associated with this company since 20 years 3 months . was completed.
Euclid Pharmaceuticals Limited was registered on 14 Nov 1990 with Roc Mumbai & aged 35 years 2 months as per MCA records. was recorded as a recent event.
The CIN of Euclid Pharmaceuticals Limited is U17120MH1990PLC058963.
Euclid Pharmaceuticals Limited is headquartered at Varsha 13 Adarsh Socramchandra Lane Extn Malad West, Mumbai, Maharashtra, 400064.
Euclid Pharmaceuticals Limited was incorporated on 14 November 1990.
The current directors of Euclid Pharmaceuticals Limited are
The primary industry of Euclid Pharmaceuticals Limited is Manufacturing.
Euclid Pharmaceuticals Limited is unlisted.
The authorized capital of Euclid Pharmaceuticals Limited is ₹5.00 M, and the paid-up capital is ₹5.00 M.
The compliance status of Euclid Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX